IJE Advance Access published online on September 15, 2009
International Journal of Epidemiology, doi:10.1093/ije/dyp301
Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2009; all rights reserved.
Commentary: Reducing HIV-associated tuberculosis in children
1School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
2School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa.
Corresponding author. School of Public Health and Family Medicine, University of Cape Town, Observatory 7925, South Africa. E-mail: andrew.boulle@uct.ac.za
Accepted 30 July 2009
| The first 10% of the full text of this article appears below. |
In both adults and children, the increased risk of tuberculosis as a result of advancing human immunodeficiency virus (HIV) infection is a major contributor to HIV-associated morbidity and mortality. This is especially so in African settings, where the background risk of tuberculosis is already high.
It is predictable that anti-retroviral therapy (ART), through allowing recovery of immune function, should reduce this increased risk in patients with HIV, and a
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in Int. J. Epidemiol.:
- Anti-retroviral therapy reduces incident tuberculosis in HIV-infected children
- Andrew Edmonds, Jean Lusiama, Sonia Napravnik, Faustin Kitetele, Annelies Van Rie, and Frieda Behets
Int. J. Epidemiol. 2009 10.1093/ije/dyp208.[Abstract] [Full Text]